Funder: National Institutes of Health
Due Dates: February 5, 2025 (New) | March 5, 2025 (Renewal/Resubmission/Revision) | May 8, 2025 (Expiration)
Funding Amounts: Up to $400,000 direct costs per year, for a maximum project period of 5 years.
Summary: Supports collaborative, multidisciplinary research to develop and characterize biomimetic tissue-engineered technologies for cancer research, expanding advanced in vitro and ex vivo models across cancer types.
Key Information: Applicants must budget for annual investigator meetings; foreign and domestic organizations are eligible; clinical trials are optional.